IL-22 Fc FUSION PROTEINS
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 14/214,161, filed Mar 14, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,815,880 | IL-22 Fc FUSION PROTEINS In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 10,087,227 | NUCLEIC ACIDS ENCODING IL-22 Fc FUSION PROTEINS In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 10,544,198 | Methods of Accelerating or Improving Wound Healing Using IL-22 FC Fusion Proteins In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 10,584,155 | PHARMACEUTICAL COMPOSITIONS OF IL-22 Fc FUSION PROTEINS In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 11,332,507 | IL-22 Fc FUSION PROTEINS In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | ||
| US 11,155,591 | METHODS OF TREATING ACUTE PANCREATITIS USING IL-22 Fc FUSION PROTEINS In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 11,130,791 | METHODS FOR TREATING METABOLIC SYNDROME USING IL-22 Fc FUSION PROTEINS In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 11,136,365 | METHODS FOR PREVENTING OR TREATING CARDIOVASCULAR CONDITIONS USING IL-22 Fc FUSION PROTEINS In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 10,160,793 | METHODS OF TREATING INFLAMMATORY BOWEL DISEASE USING IL-22 Fc FUSION PROTEINS In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | ||
| Application 15/276,511 | IL-22 Fc FUSION PROTEIN AND METHODS OF USE Abandoned Abandoned May 9, 2017 | Genentech, Inc. | Abandoned | Abandoned May 9, 2017 | ||
| 6 more patents in this group · Pro | ||||||
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16.
8 of these are in force and held by Genentech, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.